This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Zong Y, Zhou S, Sorrentino BP . Loss of P-glycoprotein expression in hematopoietic stem cells does not improve responses to imatinib in a murine model of chronic myelogenous leukemia. Leukemia 2005; 19: 1590–1596.
Rumpold H, Wolf AM, Gruenewald K, Gastl G, Gunsilius E, Wolf D . RNAi-mediated knockdown of P-glycoprotein using a transposon-based vector system durably restores imatinib sensitivity in imatinib-resistant CML cell lines. Exp Hematol 2005; 33: 767–775.
Widmer N, Colombo S, Buclin T, Decosterd LA . Functional consequence of MDR1 expression on imatinib intracellular concentrations. Blood 2003; 102: 1142.
Ferrao PT, Frost MJ, Siah SP, Ashman LK . Overexpression of P-glycoprotein in K562 cells does not confer resistance to the growth inhibitory effects of imatinib (STI571) in vitro. Blood 2003; 102: 4499–4503.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rumpold, H., Wolf, AM. & Wolf, D. The role of P-glycoporotein in imatinib resistance. Leukemia 20, 144 (2006). https://doi.org/10.1038/sj.leu.2404001
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2404001
This article is cited by
-
Resistance reversal by RNAi silencing of MDR1 in CML cells associated with increase in imatinib intracellular levels
Leukemia (2007)
-
Reply to Zong et al.
Leukemia (2007)
-
Reply to Rumpold et al
Leukemia (2006)